Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Borbath

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|February 11, 2003
The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinomaIvan Borbath, Yves Horsmans
The New England Journal of Medicine|November 2, 2022
The Zollinger-Ellison SyndromeQuentin Binet, Ivan Borbath
PPAR Research|May 30, 2008
The Role of PPARgamma in Hepatocellular CarcinomaIvan Borbath, Yves Horsmans
The Lancet. Gastroenterology & Hepatology|September 15, 2018
Chemotherapy for pancreatic cancer: the rise of multidrug regimensDavid Malka, Ivan Borbath, Thierry Conroy
Gene Expression|March 28, 2018
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?Elsa Ghurburrun, Ivan Borbath, Frédéric P Lemaigre, et al.
Acta Gastro-Enterologica Belgica|August 9, 2012
Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survivalIvan Borbath, Renaud Lhommel, Yves Guiot, et al.
Clinical Nuclear Medicine|November 6, 2018
Sorafenib Reduced Significantly Heptopulmonary Shunt in a Large Hepatocelullar CarcinomaPhilippe dʼAbadie, Ivan Borbath, Pierre Goffette, et al.
Annales D'Endocrinologie|December 7, 2020
Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinomaRaluca Maria Furnica, Pierre Deprez, Dominique Maiter, et al.
Future Oncology (London, England)|February 1, 2019
Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety dataJuan W Valle, Ivan Borbath, Brad Rosbrook, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2002
Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour modelIvan Borbath, Vincent Grégoire, Mats Bergström, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|February 11, 2003
The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinomaIvan Borbath, Yves Horsmans
The New England Journal of Medicine|November 2, 2022
The Zollinger-Ellison SyndromeQuentin Binet, Ivan Borbath
PPAR Research|May 30, 2008
The Role of PPARgamma in Hepatocellular CarcinomaIvan Borbath, Yves Horsmans
The Lancet. Gastroenterology & Hepatology|September 15, 2018
Chemotherapy for pancreatic cancer: the rise of multidrug regimensDavid Malka, Ivan Borbath, Thierry Conroy
Gene Expression|March 28, 2018
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?Elsa Ghurburrun, Ivan Borbath, Frédéric P Lemaigre, et al.
Acta Gastro-Enterologica Belgica|August 9, 2012
Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survivalIvan Borbath, Renaud Lhommel, Yves Guiot, et al.
Clinical Nuclear Medicine|November 6, 2018
Sorafenib Reduced Significantly Heptopulmonary Shunt in a Large Hepatocelullar CarcinomaPhilippe dʼAbadie, Ivan Borbath, Pierre Goffette, et al.
Annales D'Endocrinologie|December 7, 2020
Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinomaRaluca Maria Furnica, Pierre Deprez, Dominique Maiter, et al.
Future Oncology (London, England)|February 1, 2019
Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety dataJuan W Valle, Ivan Borbath, Brad Rosbrook, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2002
Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour modelIvan Borbath, Vincent Grégoire, Mats Bergström, et al.
Pageof 9